Page last updated: 2024-11-07

3-(methoxycarbonyl)amino-beta-carboline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(methoxycarbonyl)amino-beta-carboline: antagonist of sedative effects of benzodiazepines; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124760
CHEMBL ID165882
SCHEMBL ID2214365
MeSH IDM0145421

Synonyms (10)

Synonym
3-mcabc
methyl n-(9h-pyrido[3,4-b]indol-3-yl)carbamate
CHEMBL165882
91985-74-9
3-(methoxycarbonyl)amino-beta-carboline
carbamic acid, 9h-pyrido(3,4-b)indol-3-yl-, methyl ester
SCHEMBL2214365
DTXSID70919418
methyl hydrogen 9h-pyrido[3,4-b]indol-3-ylcarbonimidate
PD075748
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID40825Inhibition of [3H]- flunitrazepam binding to GABA-A Benzodiazepine receptor of rat cerebral cortex membranes1985Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
3-Amino-beta-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.19 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]